Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations
{{output}}
Randomized controlled trials (RCTs) evaluating anti-cancer agents often lack generalizability to real-world oncology patients. Although restrictive eligibility criteria contribute to this issue, the role of selection bias related to prognostic risk remains unc... ...
